Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Tumour-promoting Effect of Excessively Large Doses of Oral Griseofulvin on Tumours induced in Mice by Methylcholanthrene

Abstract

LARGE intravenous doses of griseofulvin in rats have been found to arrest mitosis in metaphase in certain organs, for example, bone marrow, seminal epithelium and intestinal epithelium. We postulated that since griseofulvin taken orally is soon found in the keratin layer of the skin, there might be an antimitotic effect with a delay in the production, and a reduction in the number, of tumours that would be produced by applications of methylcholanthrene to the epidermis of mice. A pilot experiment was performed which gave quite unexpected results.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BARICH, L., NAKAI, T., SCHWARZ, J. et al. Tumour-promoting Effect of Excessively Large Doses of Oral Griseofulvin on Tumours induced in Mice by Methylcholanthrene. Nature 187, 335–336 (1960). https://doi.org/10.1038/187335b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/187335b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing